Xvivo Perfusion AB (publ) (STO:XVIVO)

Market Cap	7.04B
Revenue (ttm)	822.93M
Net Income (ttm)	111.38M
Shares Out	31.50M
EPS (ttm)	3.50
PE Ratio	63.89
Forward PE	46.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,450
Average Volume	173,564
Open	224.60
Previous Close	223.40
Day's Range	224.20 - 227.20
52-Week Range	201.40 - 547.00
Beta	1.91
RSI	33.87
Earnings Date	Jul 11, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 190
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: XVIVO

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.